Concepedia

Author

Douglas Fleming

Royal College of General Practitioners

Also Known As

D M FLEMING, D M Fleming, D. Fleming, D. M. FLEMING, D. M. Fleming, D.M Fleming, D.M. Fleming, D. M. Fleming, Douglas Fleming, Douglas M Fleming

215

Publications

10.7K

Citations

57

H-Index

139

Concepts

All Affiliations

Royal College of General PractitionersNetherlands Institute for Health Services ResearchPublic Health EnglandHealth Protection Scotland
DF

About

Douglas Fleming is an author at Royal College of General Practitioners specializing in medicine, epidemiology, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

48

3.3K

2

Nursing

4

4

94

3

Business

1

1

41

4

Education

1

1

16

5

Health Sciences

1

1

57

Douglas Fleming

×

110

Publications

9.9K

Citations

56

H-Index

YearCitations

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

Frederick G. Hayden, Albert D. M. E. Osterhaus, John J. Treanor,

New England Journal of Medicine

1997

761

Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study

Lone Simonsen, Peter Spreeuwenberg, Roger Lustig,

PLoS Medicine

2013

490

Prevalence of asthma and hay fever in England and Wales.

Douglas Fleming, D. L. Crombie

BMJ

1987

384

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

Matthew H. Kulke, Dieter Hörsch, Martyn Caplin,

Journal of Clinical Oncology

2017

299

Human<i>Metapneumovirus</i>as a Cause of Community-Acquired Respiratory Illness1

Joanne Stockton, Iain Stephenson, Douglas Fleming,

Emerging infectious diseases

2002

292

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus Infections

Arnold S. Monto, Douglas Fleming, D. Henry,

The Journal of Infectious Diseases

1999

276

Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma

Douglas Fleming, Pietro Crovari, Ulrich Wahn,

The Pediatric Infectious Disease Journal

2006

273

The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy

Deborah Cromer, Albert Jan van Hoek, Mark Jit,

Journal of Infection

2013

244

Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

Douglas Fleming, Robert J. Taylor, Roger Lustig,

BMC Infectious Diseases

2015

232

Potential Impact of Antiviral Drug Use during Influenza Pandemic

Raymond Gani, Helen E. Hughes, Douglas Fleming,

Emerging infectious diseases

2005

209

Page 1